|
1
|
Pandol S, Gukovskaya A, Edderkaoui M,
Dawson D, Eibl G and Lugea A: Epidemiology, risk factors and the
promotion of pancreatic cancer: Role of the stellate cell. J
Gastroenterol Hepatol. 27(Suppl 2): S127–S134. 2012. View Article : Google Scholar
|
|
2
|
Siegel R, Ma J, Zou Z and Jemal A: Cancer
statistics, 2014. CA Cancer J Clin. 64:9–29. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Vincent A, Herman J, Schulick R, Hruban RH
and Goggins M: Pancreatic cancer. Lancet. 378:607–620. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Maitra A, Kern SE and Hruban RH: Molecular
pathogenesis of pancreatic cancer. Best Pract Res Clin
Gastroenterol. 20:211–226. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Moore PS, Sipos B, Orlandini S, Sorio C,
Real FX, Lemoine NR, Gress T, Bassi C, Klöppel G, Kalthoff H, et
al: Genetic profile of 22 pancreatic carcinoma cell lines. Analysis
of K-ras, p53, p16 and DPC4/Smad4. Virchows Arch. 439:798–802.
2001. View Article : Google Scholar
|
|
6
|
Li D, Xie K, Wolff R and Abbruzzese JL:
Pancreatic cancer. Lancet. 363:1049–1057. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Logan CY and Nusse R: The Wnt signaling
pathway in development and disease. Annu Rev Cell Dev Biol.
20:781–810. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Qian D, Jones C, Rzadzinska A, Mark S,
Zhang X, Steel K, Dai X and Chen P: Wnt5a functions in planar cell
polarity regulation in mice. Dev Biol. 306:121–133. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Clevers H: Wnt/beta-catenin signaling in
development and disease. Cell. 127:469–480. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Wong GT, Gavin BJ and McMahon AP:
Differential transformation of mammary epithelial cells by Wnt
genes. Mol Cell Biol. 14:6278–6286. 1994. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Fang DR, Lv ZF and Qiao G: Dynamic Wnt5a
expression in murine hair follicle cycle and its inhibitory effects
on follicular. Asian Pac J Trop Med. 7:285–288. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Maeda K, Kobayashi Y, Udagawa N, Uehara S,
Ishihara A, Mizoguchi T, Kikuchi Y, Takada I, Kato S, Kani S, et
al: Wnt5a-Ror2 signaling between osteoblast-lineage cells and
osteoclast precursors enhances osteoclastogenesis. Nat Med.
18:405–412. 2012. View
Article : Google Scholar : PubMed/NCBI
|
|
13
|
Christman MA 2nd, Goetz DJ, Dickerson E,
McCall KD, Lewis CJ, Benencia F, Silver MJ, Kohn LD and Malgor R:
Wnt5a is expressed in murine and human atherosclerotic lesions. Am
J Physiol Heart Circ Physiol. 294:2864–2870. 2008. View Article : Google Scholar
|
|
14
|
Bakker ER, Das AM, Helvensteijn W, Franken
PF, Swagemakers S, van der Valk MA, ten Hagen TL, Kuipers EJ, van
Veelen W and Smits R: Wnt5a promotes human colon cancer cell
migration and invasion but does not augment intestinal
tumorigenesis in Apc1638N mice. Carcinogenesis. 34:2629–2638. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Trifa F, Karray-Chouayekh S, Jmal E, Jmaa
ZB, Khabir A, Sellami-Boudawara T, Frikha M, Daoud J and
Mokdad-Gargouri R: Loss of WIF-1 and Wnt5a expression is related to
aggressiveness of sporadic breast cancer in Tunisian patients.
Tumour Biol. 34:1625–1633. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Lee SE, Lim SD, Kang SY, Suh SB and Suh
YL: Prognostic significance of Ror2 and Wnt5a expression in
medulloblastoma. Brain Pathology. 23:445–453. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Bo H, Zhang S, Gao L, Chen Y, Zhang J,
Chang X and Zhu M: Upregulation of Wnt5a promotes epithelial- to
mesenchymal transition and metastasis of pancreatic cancer cells.
BMC Cancer. 13:4962013. View Article : Google Scholar
|
|
18
|
Nishita M, Yoo SK, Nomachi A, Kani S,
Sougawa N, Ohta Y, Takada S, Kikuchi A and Minami Y: Filopodia
formation mediated by receptor tyrosine kinase Ror2 is required for
Wnt5a-induced cell migration. J Cell Biol. 175:555–562. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Matsumoto S, Fumoto K, Okamoto T, Kaibuchi
K and Kikuchi A: Binding of APC and dishevelled mediates
Wnt5a-regulated focal adhesion dynamics in migrating cells. EMBO J.
29:1192–1204. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Yamamoto H, Kitadai Y, Yamamoto H, Oue N,
Ohdan H, Yasui W and Kikuchi A: Laminin gamma2 mediates
Wnt5a-induced invasion of gastric cancer cells. Gastroenterology.
137:242–252. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Lehtonen A, Ahlfors H, Veckman V,
Miettinen M, Lahesmaa R and Julkunen I: Gene expression profiling
during differentiation of human monocytes to macrophages or
dendritic cells. J Leukoc Biol. 82:710–720. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Yamamoto H, Oue N, Sato A, Hasegawa Y,
Yamamoto H, Matsubara A, Yasui W and Kikuchi A: Wnt5a signaling is
involved in the aggressiveness of prostate cancer and expression of
metalloproteinase. Oncogene. 29:2036–2046. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Huang CL, Liu D, Nakano J, Ishikawa S,
Kontani K, Yokomise H and Ueno M: Wnt5a expression is associated
with the tumor proliferation and the stromal vascular endothelial
growth factor-an expression in non-small-cell lung cancer. J Clin
Oncol. 23:8765–8773. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Kremenevskaja N, von Wasielewski R, Rao
AS, Schöfl C, Andersson T and Brabant G: Wnt-5a has tumor
suppressor activity in thyroid carcinoma. Oncogene. 24:2144–2154.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Ripka S, Konig A, Buchholz M, Wagner M,
Sipos B, Kloppel G, Downward J, Gress T and Michl P: WNT5A-target
of CUTL1 and potent modulator of tumor cell migration and invasion
in pancreatic cancer. Carcinogenesis. 28:1178–1187. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Li J, Ying J, Fan Y, Wu L, Ying Y, Chan
AT, Srivastava G and Tao Q: WNT5A antagonizes WNT/β-catenin
signaling and is frequently silenced by promoter CpG methylation in
esophageal squamous cell carcinoma. Cancer Biol Ther. 10:617–624.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Ying J, Li H, Yu J, Ng KM, Poon FF, Wong
SC, Chan AT, Sung JJ and Tao Q: WNT5A exhibits tumor-suppressive
activity through antagonizing the Wnt/beta-catenin signaling, and
is frequently methylated in colorectal cancer. Clin Cancer Res.
14:55–61. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Ying J, Li H, Chen YW, Srivastava G, Gao Z
and Tao Q: WNT5A is epigenetically silenced in hematologic
malignancies and inhibits leukemia cell growth as a tumor
suppressor. Blood. 110:4130–4131. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Torii K, Nishizawa K, Kawasaki A,
Yamashita Y, Katada M, Ito M, Nishimoto I, Terashita K, Aiso S and
Matsuoka M: Anti-apoptotic action of Wnt5a in dermal fibroblasts is
mediated by the PKA signaling pathways. Cell Signal. 20:1256–1266.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Jia L, Miao C, Cao Y and Duan EK: Effects
of Wnt proteins on cell proliferation and apoptosis in HEK293
cells. Cell Biol Int. 32:807–813. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Almeida M, Han L, Bellido T, Manolagas SC
and Kousteni S: Wnt proteins prevent apoptosis of both uncommitted
osteoblast progenitors and differentiated osteoblasts by
beta-catenin-dependent and -independent signaling cascades
involving Src/ERK and phosphatidylinositol 3-kinase/AKT. J Biol
Chem. 280:41342–41351. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Kim J, Kim DW, Chang W, Choe J, Kim J,
Park CS, Song K and Lee I: Wnt5a is secreted by follicular
dendritic cells to protect germinal center B cells via
Wnt/Ca2+/NFAT/NF-κB-B cell lymphoma 6 signaling. J Immunol.
188:182–189. 2012. View Article : Google Scholar
|
|
33
|
Vuga LJ, Ben-Yehudah A,
Kovkarova-Naumovski E, Oriss T, Gibson KF, Feghali-Bostwick C and
Kaminski N: WNT5A is a regulator of fibroblast proliferation and
resistance to apoptosis. Am J Respir Cell Mol Biol. 41:583–589.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Liang H, Coles AH, Zhu Z, Zayas J, Jurecic
R, Kang J and Jones SN: Noncanonical Wnt signaling promotes
apoptosis in thymocyte development. J Exp Med. 204:3077–3084. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Peng S, Zhang J, Chen J and Wang H:
Effects of Wnt5a protein on proliferation and apoptosis in JAR
choriocarcinoma cells. Mol Med Report. 4:99–104. 2011.
|
|
36
|
Umbhauer M, Djiane A, Goisset C,
Penzo-Méndez A, Riou JF, Boucaut JC and Shi DL: The C-terminal
cytoplasmic Lys-thr-X-X-X-Trp motif in frizzled receptors mediates
Wnt/beta-catenin signaling. EMBO J. 19:4944–4954. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Mikels AJ and Nusse R: Purified Wnt5a
protein activates or inhibits beta-catenin-TCF signaling depending
on receptor context. PLoS Biol. 4:e1152006. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
van Amerongen R, Fuerer C, Mizutani M and
Nusse R: Wnt5a can both activate and repress Wnt/β-catenin
signaling during mouse embryonic development. Dev Biol.
369:101–114. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Wang L, Heidt DG, Lee CJ, Yang H, Logsdon
CD, Zhang L, Fearon ER, Ljungman M and Simeone DM: Oncogenic
function of ATDC in pancreatic cancer through Wnt pathway
activation and beta-catenin stabilization. Cancer Cell. 15:207–219.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Kobayashi T, Shimura T, Yajima T, Kubo N,
Araki K, Tsutsumi S, Suzuki H, Kuwano H and Raz A: Transient gene
silencing of galectin-3 suppresses pancreatic cancer cell migration
and invasion through degradation of β-catenin. Int J Cancer.
129:2775–2786. 2011. View Article : Google Scholar : PubMed/NCBI
|
